Cardiac resynchronisation therapy in heart failure: Current status

Heart Failure Reviews

Volumn 11, Issue 2, 2006, Pages 147-154

  Daubert, J Claude ^a   Leclercq, Christophe ^a   Donal, Erwan ^a   Mabo, Philippe ^a  

^a RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

Biventricular pacing; Cardiac resynchronization; Intracardiac defibrillators; QRS duration; Ventricular dyssynchrony

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVERSION; CLINICAL DECISION MAKING; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEATH; DEFIBRILLATION; DISEASE CLASSIFICATION; DRUG COST; EQUIPMENT DESIGN; EVIDENCE BASED MEDICINE; EXERCISE TOLERANCE; FOLLOW UP; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE POTENTIAL; HOSPITALIZATION; HUMAN; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATIENT SELECTION; QRS COMPLEX; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUESTIONNAIRE; SURVIVAL RATE; SYMPTOM; TREATMENT INDICATION; TREATMENT OUTCOME;

CARDIAC PACING, ARTIFICIAL; HEART FAILURE; HEART FAILURE, CONGESTIVE; HUMANS; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX;

EID: 33747880670     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10741-006-9485-9     Document Type: Article

References (57)

1. Vagnini FJ, Gourin A, Antell HI, Stuckey JH. Implantation sites of cardiac pacemaker electrodes and myocardial contractility. Ann Thorac Surg 1967;4(5):431-9.
2. Tyers GF. Comparison of the effect on cardiac function of single-site and simultaneous multiple-site ventricular stimulation after A-V block. J Thorac Cardiovasc Surg 1970;59(2):211-7.
3. Gibson DG, Chamberlain DA, Coltart DJ, Mercer J. Effect of changes in ventricular activation on cardiac haemodynamics in man. Comparison of right ventricular, left ventricular, and simultaneous pacing of both ventricles. Br Heart J 1971;33(3):397-400.
4. De Teresa E, Chamoro JL, Pupon A. An even more physiological pacing: changing the sequence of ventricular acxtivation. In E Steinbach (Eds), Proccedings of the VIIth world congress on cardiac pacing. Vienna, Austria, 1983, pp. 95-100.
5. Cazeau S, Ritter P, Bakdach S, et al. Four chamber pacing in dilated cardiomyopathy. Pacing Clin Electrophysiol 1994;17:1974-1979.
6. Bakker P, Meijburg H, De Jonghe N, et al. Beneficial effects of biventricular pacing in congestive heart failure. Pacing Clin Electrophysiol 1994;17:820(abstract).
7. Vernooy K, Verbeek XAAM, Peschar M, et al. Left bundle branch block induces ventricular remodelling and functional septal hypoperfusion. Eur Heart J 2005;26:91-98.
8. Spragg DD, Leclercq, Loghmani M, et al. Regional alterations in protein expression in the dyssynchronous failing heart. Circulation 2003;108:929-932.
9. Nowak B, Sinha A, Schaefer W, et al. Cardiac resynchronization therapy homogenizes myocardial glucose metabolism and perfusion in dilated cardiomyopathy and left bundle branch block. J Am Coll Cardiol 2003;41:1523-28.
10. Ukkonenen H, Beanlands R, Burwash I, et al. Effect of cardiac resynchronization on myocardial efficiency and regioanl oxidative metabolism. Circulation 2003;107:28-31.
11. Sundell J, Engblom E, Koistinen J, et al. The effects of cardiac resynchronization therapy on left vnetricular function? myocardial energetics? and metabolic reserve in patients with dilated cardiomyopathy and heart failure. J Am Coll Cardiol 2004;43:1027-1033.
12. Alonso C, Leclercq C, Victor F, et al. Electrocardiographic predictive factors of long-term clinical improvement with multisite biventricular pacing in advanced heart failure. Am J Cardiol 1999;84:1417-21.
13. Leclercq C, Cazeau S, Ritter P, et al. A pilot experience with permanent biventricular pacing to treat advanced heart failure. Am Heart J 2000;140:862-870.
14. Bakker PF, Meijburg H, de Vries JW, et al. Biventricular pacing in end-stage heart failure improves functional capacity and left ventricular function. J Intervent Card Electrophysiol 2000;4:395-404.
15. Ricci R, Ansalone G, Tosacano S, et al. Cardiac resynchronization: Materials, technique, and results. The InSync Italian Registry. Eur Heart J 2000;2:J6-15.
16. Gras D, Leclercq C, Tang AS, Bucknall C, Luttikhuis HO, Kirstein-Pedersen A. Cardiac resynchronization therapy in advanced heart failure the multicenter InSync clinical study. Eur J Heart Fail 2002;4:311-320.
17. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80.
18. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53.
19. Auricchio A, Stellbrink C, Sack S, et al. Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026-2033.
20. Auricchio A, Stellbrink C, Butter C, et al. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol 2003;42:2109-16.
21. Higgins S, Hummel J, Niazi I, et al. Cardiac resynchronization therapy for the treatment of herat failure in patients with intraventricualr conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003;42:1454-9.
22. Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioverter defibrillation in advanced chronic heart failure: The MIRACLE ICD trial. JAMA 2003;289:2685-2694.
23. Abraham WT, Young JB, Leon AR, et al. Multicenter InSync ICD II Study Group. Effects of cardiac resynchronization on disease progression in patients with left ventricular dysfunction, an indication for an implantable cardioverter-defibrillator, and midly symptomatic heart failure. Circulation 2004;110:2864-2868.
24. Bristow MR, Saxon LA, Boehmer J, et al. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-2150.
25. Cleland JGF, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization therapy on morbidity and mortality in heart failure (the CArdiac REsynchronization-Heart Failure [CARE-HF] Trial). N Eng J Med 2005;352:1539-1549.
26. Bradley D, Bradley E, Baughmann, et al. Cardiac resynchronization and death from progressive heart failure. JAMA 2003;289:730-740.
27. Mc Alister EA, Ezekowitz JA, Wiebe N, et al. Systematic review: Cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med 200';141:381-390.
28. Linde C, Leclercq C, Rex S, et al. Long-terms benefits of biventricular pacing in congestive heart failure: Results from the MUSTIC study. J Am Coll Cardiol 2002;40:111-118.
29. Duncan A, Wait D, Gibson D, et al. Left ventricular remodeling and hemodynamic effects of multisite pacing in patients with left systolic dysfunction and activation disturbances in sinus rhythm: Sub-study of the MUSTIC trial. Eur Heart J 2003;24:430-441.
30. Stellbrink C, Breithardt, O, Franke A. Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. J Am Coll Cardiol 2001;38:1957-1965.
31. St John Sutton M, Plappert T, Abraham W, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003;107:1985-1990.
32. Braunschweig F, Linde C, Gadler F, et al. Reduction of hospital days by biventricular pacing. Eur J Heart Fail 2000;24:399-406.
33. Curnis A, Caprari F, Mascioli G. Biventricular resynchronization: Cost and effectiveness analysis. Pharmacoeconomics 2003;5:11-22.
34. Leclercq C, Hare J. Ventricular resynchronization. Current state of the art. Circulation 2004;10:296-299.
35. Freemantle N on behalf of the CARE-HF Investigators. Cost-Effectiveness of Cardiac Resynchronisation Therapy (Results of the main study). Presentation in the Clinical Trials Update II session, ESC congress, Stockholm, Sept 7, 2005 (on-line: http://www.escardio.org).
36. Bleeker G, Schalij, Molhoek S, et al. Frequency of left ventricular dyssynchrony in patients with heart failure and a narrow QRS complex. Am J Cardiol 2005;95:140-142.
37. Ghio S, Constantin C, Klersy C, et al. Interventricular and intraventricular dysynchrony are common in heart failure patients, regardless of QRS duration. Eur Heart J 2004;25:571-578.
38. Bader H, Garrigue S, Lafitte S, et al. Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients. J Am Coll Cardiol 2004;43:248-256.
39. Bax J, Bleeker JB, Molhoek SG, et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardilo; 2004;44:1834-1840.
40. Achilli A, Sassara M, Ficili S, et al. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory herat failure and narrow QRS. J Am Coll Cardiol 2003;42:2117-2124.
41. Gasparini M, Mantica M, Galimberti P, et al. Beneficial effects of biventricular pacing in patients with a narrow QRS. Pacing Clin Electrophysiol 2003;26:169-174
42. Baldasseroni S, Opasich C, Gorini M, et al. Left bundle branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: A report from the Italian network on congestive heart failure. Am Heart J 2002;143:398-405.
43. Leclercq C, Walker S, Linde C, et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002;23:1780-1787.
44. Brignole F, Gammage M, Puggioni E, et al. Comparative assessment of right, left, and bivnetricular pacing in patients with permanent atrial fibrillation. Eur Heart J 2005;7:712-722.
45. Post AV Nodal Ablation Evaluation (PAVE) trial. http://www.heartrhythmfoundation.org/research/pave/default.asp
46. Cohn JN, Ferrari R, Sharpe N. Cardiac remodelling: Concept and clinical implications. A consensus paper from an international forum on cardiac remodelling. J Am Coll Cardiol 2000;35:569-582.
47. Bardy G, Lee KL, Mark DB, et al. (SCD-HeFT study).Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237.
48. Packer M. Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Card Fail 2001;7:176-182.
49. Linde C, Abraham W, Gold M, Daubert C. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic or mild heart failure: The REVERSE study. Am Heart J (2005, in press).
50. Blanc JJ, Etienne Y, Gilard M, et al. Evaluation of different ventricular pacing sites in patients with severe heart failure: Results of an acute hemodynamic study. Circulation 1997;96:3273-3277.
51. Kass DA, Chen CH, Curry C, et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999;99:1567-1573.
52. Leclercq C, Faris O, Tunin R, et al. Systolic improvement and mechanical resynchronization does not require electrical synchrony in the dilated failing heart with left bundle-branch block. Circulation 2002;106:1760-1763
53. Blanc JJ, Bertaut-Valls V, Fatemi M, et al. Midterm benefits of left univentricular pacing in patients with congestive heart failure. Circulation 2004 13;109:1741-1744.
54. De Lurgio DB, Foster E, Higginbotham MB, Larntz K, Saxon LA. A comparison of cardiac resynchronisation therapy by sequential biventricular pacing and left ventricular pacing to simultaneous biventricular pacing: Rationale and design of the DECREASE-HF clinical trial. J Cardiac Failure 2005;11:233-239.
55. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL, Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-2007.
56. Swedberg K, Cleland JGF, Dargie H, et al. Task Force for the diagnosis and treatment of chronic heart failure of the european society of cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: Update 2005. Eur Heart J 2005;2005;26:1115-1140.
57. St. John Sutton MG, Plappert T, Hilpisch KE, et al. Sustained reverse left ventricular structural remodelling with cardiac resynchronization at one year is a function of etiology. Circulation 2006;113:266-272.